Rare diseases
Investigational molecules
Locations
Back to Italy27 clinical trials in Grosseto, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
ItalyStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
ItalyStudy Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery
ItalyStudy Comparing Olaparib and Chemotherapy for Patients with Recurrent Ovarian Cancer After Surgery
ItalyStudy Comparing Atezolizumab Alone and Atezolizumab with Bevacizumab for First-Line Treatment in Patients with Advanced Non-Small-Cell Lung Cancer
ItalyStudy on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer
ItalyStudy of Atezolizumab with Drug Combination for Patients with Unresectable Metastatic Colorectal Cancer
ItalyStudy on the Effectiveness of Oxygen for Patients with Intermediate-Risk Acute Pulmonary Embolism
ItalyItalyPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
ItalyOsimertinib and drug combination in metastatic non‑small cell lung cancer with targetable genomic driver alterations
ItalyStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
ItalyThe busiest research cities in the country
What the registry says about research in the country
Studies focusing on cardiogenic shock treatment strategies and innovative approaches for managing acute myocardial infarction. Research includes evaluating medications like evolocumab and investigating treatments for cardiovascular disease prevention.
Novel therapeutic approaches comparing different medication combinations to improve patient outcomes.
Comprehensive research into various cancer types, with particular focus on breast cancer and colorectal cancer treatments. Studies evaluate new drug combinations and maintenance therapies.
Investigating targeted therapies and immunotherapy approaches for better treatment outcomes.
Studies examining treatment optimization for HIV-1 infected individuals, focusing on evaluating two-drug versus three-drug regimens and their long-term effectiveness.
Research aims to improve treatment efficiency while maintaining viral suppression.
Investigation of innovative treatments for Parkinson's disease, including continuous subcutaneous medication delivery systems to improve motor function control.
Focus on improving quality of life for patients with movement disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
